Jaguar Health (NASDAQ:JAGX) Share Price Passes Above 50-Day Moving Average – Here’s Why

Jaguar Health, Inc. (NASDAQ:JAGX)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares changing hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.

Jaguar Health Price Performance

The stock’s 50 day moving average price is $1.02 and its 200 day moving average price is $1.52. The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 12.04% of the company’s stock.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.